Azlaire (pranlukast) / Merck (MSD), Ono Pharma - LARVOL DELTA

Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. (PubMed) - Eur Arch Otorhinolaryngol - "Antileukotrienes reduce the apnea-hypopnea index and adenotonsillar inflammation. Antileukotrienes may be useful for children with adenotonsillar hypertrophy due to their anti-inflammatory effects, which help to reduce adenotonsillar inflammation."

Journal • Review • Biosimilar • Immunology

An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327) (clinicaltrials.gov) - P3; N=1375; Completed; Sponsor: Merck Sharp & Dohme Corp.; Initiation date: Nov 2001 ->Nov 2004

Trial initiation date • Biosimilar • Immunology